Although Aduhelm, a monoclonal antibody targeting amyloid beta (Aβ), recently became the first US FDA approved drug for Alzheimer's disease (AD) based on its ability to decrease Aβ plaque burden in AD patients, its effect ...
Aug 4, 2022
0
42
Disease of the microscopic blood vessels that feed the white matter of our brain is associated with worse cognitive function and memory deficits in individuals with Alzheimer's, scientists report.
Aug 2, 2022
0
630
Alzheimer's disease can begin almost imperceptibly, often masquerading in the early months or years as forgetfulness that is common in older age. What causes the disease remains largely a mystery.
Jul 29, 2022
7
1401
An advanced form of cardiac MRI, developed by academics at UCL in collaboration with the Royal Free Hospital, has for the first-time enabled clinicians to measure the effectiveness of chemotherapy in patients with the life-limiting ...
Jul 28, 2022
0
95
A novel, disease-modifying therapy for Alzheimer's disease may involve the whole exchange of blood, which effectively decreased the formation of amyloid plaque in the brains of mice, according to a new study from UTHealth ...
Jul 14, 2022
0
185
La Trobe University-led research may have uncovered the cause of the neurological conditions seen in patients with long COVID, such as brain fog.
Jun 16, 2022
0
132
A simple blood test to diagnose Alzheimer's disease, perhaps even years before symptoms appear, is an exciting possibility, but a new study shows that much more research is needed before these blood tests are routinely used ...
May 26, 2022
0
39
For more than 20 years, scientists have known that people with hypertension, diabetes, high cholesterol, or obesity have a higher likelihood of developing Alzheimer's disease.
May 25, 2022
0
445
QUT genetic researchers have found blood proteins that cause migraine and have a shared link with Alzheimer's disease that could potentially be prevented by repurposing existing therapeutics.
May 12, 2022
0
82
During experiments in animal models, researchers at the University of Kansas have discovered a possible new approach to immunization against Alzheimer's disease (AD).
May 3, 2022
0
114
